SCHEMBL9723153

SCHEMBL9723153

CCCCCCCCCc1ccc(-c2ncc(CCCCCCCCC)cn2)cc1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.79
▸ RAB9A P51151 4/20 0.79
▸ SMN1; SMN2 Q16637 3/20 0.79
▸ ALDH1A1 P00352 3/20 0.79
▸ HSD17B10 Q99714 3/20 0.79
▸ MEN1 O00255 2/20 0.79
▸ KMT2A Q03164 2/20 0.79
▸ KDM4E B2RXH2 2/20 0.79
▸ USP2 O75604 1/20 0.79
▸ GAA P10253 1/20 0.79
▸ HPGD P15428 1/20 0.79
▸ RARB P10826 6/20 0.72
▸ NPC1 O15118 2/20 0.56
▸ STAT3 P40763 1/20 0.56
▸ ATM Q13315 1/20 0.56
▸ RARA P10276 1/20 0.54
▸ MTOR P42345 1/20 0.54
▸ NFKB1 P19838 1/20 0.52
▸ NFKB2 Q00653 1/20 0.52
▸ RELA Q04206 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9403673 1.00 MAPT (0.79) MAPTRAB9ASMN1; SMN2ALDH1A1HSD17B10
SCHEMBL10346231 1.00 MAPT (0.79) MAPTRAB9ASMN1; SMN2ALDH1A1HSD17B10
SCHEMBL10482122 1.00 MAPT (0.79) MAPTRAB9ASMN1; SMN2ALDH1A1HSD17B10
SCHEMBL9850179 1.00 MAPT (0.79) MAPTRAB9ASMN1; SMN2ALDH1A1HSD17B10
SCHEMBL9850118 1.00 MAPT (0.79) MAPTRAB9ASMN1; SMN2ALDH1A1HSD17B10
SCHEMBL9850122 1.00 MAPT (0.79) MAPTRAB9ASMN1; SMN2ALDH1A1HSD17B10
SCHEMBL9850258 1.00 MAPT (0.79) MAPTRAB9ASMN1; SMN2ALDH1A1HSD17B10
SCHEMBL9850155 1.00 MAPT (0.79) MAPTRAB9ASMN1; SMN2ALDH1A1HSD17B10
SCHEMBL9850312 1.00 MAPT (0.79) MAPTRAB9ASMN1; SMN2ALDH1A1HSD17B10
SCHEMBL9850137 1.00 MAPT (0.79) MAPTRAB9ASMN1; SMN2ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8956705-B2 Ferroelectric liquid crystal (FLC) polymers CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2015-02-17 — — US disclosed
US-8956705-B2 Ferroelectric liquid crystal (FLC) polymers CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2015-02-17 — — US disclosed
US-8778223-B2 Liquid crystals having cyclohexyl core structures and fluorinated tails LC VISION, LLC (US) 2014-07-15 — — US disclosed
US-8778223-B2 Liquid crystals having cyclohexyl core structures and fluorinated tails LC VISION, LLC (US) 2014-07-15 — — US disclosed
US-20120326083-A1 LIQUID CRYSTALS HAVING CYCLOHEXYL CORE STRUCTURES AND FLUORINATED TAILS LC VISION, LLC 2012-12-27 — — US disclosed
US-20100220279-A1 FERROELECTRIC LIQUID CRYSTAL (FLC) POLYMERS NATIONAL SCIENCE FOUNDATION 2010-09-02 — — US disclosed
US-5089168-A Stable ferroelectric liquid crystals MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1992-02-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120326083-A1 LIQUID CRYSTALS HAVING CYCLOHEXYL CORE STRUCTURES AND FLUORINATED TAILS Q6ZSR9, CRACR2A, RCC1 MAPT 295/4885RAB9A 2644/4885SMN1; SMN2 3431/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback